Navigation Links
Ovarian Cyst Syndrome May Raise Health Risks from Plastics Chemical
Date:1/18/2011

TUESDAY, Jan. 18 (HealthDay News) -- Women with polycystic ovary syndrome (PCOS) appear to be more vulnerable to a chemical found in many consumer products than other women, a new study suggests.

Bisphenol A, or BPA, is widely used in plastic products, food and drink packaging and even dental materials. PCOS, a common endocrine disorder in women of reproductive age, is characterized by excessive production of male sex hormones (androgens). PCOS raises the chances of obesity, type 2 diabetes, infertility and heart disease.

In this study, Greek researchers checked blood levels of BPA in 71 women with PCOS and a control group of 100 women without the syndrome. Compared to the control group, BPA levels were nearly 60 percent higher in lean women with PCOS and nearly 30 percent higher in obese women with PCOS.

As BPA levels increased, so did concentrations of the male sex hormones testosterone and androstenedione, a steroid hormone that converts to testosterone.

The study findings are scheduled for publication in the March issue of the Journal of Clinical Endocrinology & Metabolism.

"Excessive secretion of androgens, as seen in PCOS, interfere with BPA detoxification by the liver, leading to accumulation of blood levels of BPA," study co-author Dr. Evanthia Diamanti-Kandarakis, a professor at the University of Athens Medical School, explained in a news release from the Endocrine Society. "BPA also affects androgen metabolism, creating a vicious circle between androgens and BPA."

According to Diamanti-Kandarakis, the study "shows that BPA may be more harmful to women with hormonal and fertility imbalances like those found in PCOS. These women should be alert to the potential risks and take care of themselves by avoiding excessive everyday consumption of food or drink from plastic containers."

More information

WomensHealth.gov has more about polycystic ovary syndrome.

-- Robert Preidt

SOURCE: The Endocrine Society, news release, Jan. 12, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. UH biochemist works to revolutionize ovarian cancer treatment
2. Ovarian cancer advances when genes are silenced
3. Few Lives Saved by Ovarian Cancer Screening: Study
4. Biological diversity of ovarian cancer lessens value of screening
5. Researchers map the way to personalised treatment for ovarian cancer
6. Menopausal hormone therapy may increase risk of ovarian cancer
7. Peptide being tested to treat atherosclerosis inhibits ovarian cancer growth
8. Dads Family History of Breast, Ovarian Cancer Matters, Too
9. VCA fellowship funding to extend ovarian cancer research
10. Estrogen replacement therapy speeds ovarian cancer growth, new study reports
11. Girls with ovarian germ-cell tumors can safely skip chemotherapy unless disease recurs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ovarian Cyst Syndrome May Raise Health Risks from Plastics Chemical 
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
Breaking Medicine Technology: